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ABSTRACT 
Objective Little is known about the impact of exercise training on conduit artery wall thickness 
in type 2 diabetes. We examined the local and systemic impact of exercise training on superficial 
femoral (SFA), brachial (BA), and carotid artery (CA) wall thickness in type 2 diabetes patients 
and controls.  
Methods Twenty patients with type 2 diabetes and 10 age- and sex-matched controls performed 
an 8-week training study involving lower-limb based combined aerobic and resistance exercise 
training. We examined the SFA to study the local effect of exercise, and also the systemic impact 
of lower-limb based exercise training on peripheral (i.e. BA) and central (i.e. CA) arteries. Wall 
thickness (WT), diameter and wall:lumen(W:L)-ratios were examined using automated edge-
detection of ultrasound images.  
Results Exercise training did not alter SFA or CA diameter in type 2 diabetes or controls (all 
P>0.05). BA diameter was increased after training in type 2 diabetes, but not in controls. 
Exercise training decreased WT and W:L-ratio in the SFA and BA, but not in CA in type 2 
diabetes. Training did not alter WT or W:L-ratio in controls (P>0.05). 
Conclusion Lower-limb dominant exercise training causes remodelling of peripheral arteries, 
supplying active and inactive vascular beds, but not central arteries in type 2 diabetes. 
 
KEYWORDS: intima-media thickness; cardiovascular risk; exercise training; arterial 
remodelling 
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ABBREVIATIONS 
BA Brachial Artery 
CA Carotid Artery 
CV Coefficient of Variation 
HDL High Density Lipoprotein 
LDL Low Density Lipoprotein 
ROI Region of Interest 
SD Standard Deviation 
SE Standard Error 
SFA Superficial Femoral Artery 
 
4 
 
INTRODUCTION  
Exercise training is an important adjunct to medical therapy in type 2 diabetes which is 
associated with improved glucose homeostasis (Marwick et al. 2009; Wei et al. 2000). In 
addition, regular exercise training has strong and independent cardioprotective effects, leading to 
lower cardiovascular morbidity and mortality in type 2 diabetes (Church et al. 2004). These 
effects of exercise training may, at least partly, be mediated through the direct effect of exercise 
on the arterial wall (Green et al. 2008; Joyner and Green 2009). Indeed, exercise training 
improves vascular function measured as flow-mediated dilation in peripheral vessels in type 2 
diabetes, most likely contributing to the cardioprotective effects of exercise training (Thijssen et 
al. 2010; Maiorana et al. 2001; Xiang and Wang 2004). 
 
Little attention has been paid to the impact of exercise training in type 2 diabetes on arterial wall 
thickness (WT); a surrogate measure of atherosclerosis (de Groot et al. 2004; Lorenz et al. 2007), 
which has been shown to be increased in subjects with type 2 diabetes (Metcalf et al. 2000; 
Wagenknecht et al. 1997; Wagenknecht et al. 1998). Cross-sectional studies in healthy subjects 
demonstrated that athletes have a generally lower artery wall thickness compared to sedentary 
controls (Rowley et al. 2012; Rowley et al. 2011; Maiorana et al. 2011). A recent study in 
healthy young men confirmed the presence of a generalised decrease in arterial wall thickness 
after 8-weeks cycling exercise training (3 sessions per week) on both the carotid and the 
superficial femoral artery (Thijssen et al. 2013). However, the effects of exercise training on wall 
thickness may be different in subjects with increased cardiovascular risk, such as type 2 diabetes. 
Endurance trained post-menopausal women show a smaller wall thickness in peripheral (i.e. 
superficial femoral artery (SFA)), but not the carotid artery (CA), compared to sedentary controls 
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(Moreau et al. 2002). These findings raise the possibility that exercise training may induce site-
specific changes in wall thickness, with predominance in peripheral vessels, especially in 
subjects with a priori increased cardiovascular risk such as type 2 diabetes. 
 
Reduced wall thickness of the carotid artery (O'Leary et al. 1999), but also of peripheral vessels 
such as the brachial artery (BA) (Sorensen et al. 1997; Suessenbacher et al.) and SFA (Paul et al. 
2005), is associated with reduced risk of cardiovascular events. Exercise training-induced 
remodeling in wall thickness may, therefore, have prognostic implications. Evidence indicates an 
inverse relationship between physical fitness and carotid intima-media thickness in type 2 
diabetes (Jae et al. 2012), whilst a recent study provided evidence that aerobic exercise training 
attenuates CA wall thickness (Kadoglou et al. 2013). However, relatively little is known about 
the potential impact of exercise training on wall thickness of peripheral arteries in type 2 
diabetes, and whether changes in peripheral arteries are in agreement with central conduit artery 
wall thickness. We, therefore, examined the impact of 8 weeks of supervised exercise training on 
wall thickness in peripheral (SFA and BA) and central (CA) vessels in type 2 diabetes and 
controls. By performance of lower limb-dominant exercise, we can distinguish between the 
impact of exercise on peripheral arteries supplying active (i.e SFA) versus inactive (i.e. BA) 
areas. We hypothesise that training would result in a generalised decrease in wall thickness in 
controls, and in a decrease in wall thickness of peripheral, but not central arteries in type 2 
diabetes. 
 
6 
 
METHODS 
Subjects 
Twenty sedentary (i.e. no regular physical exercise) men with type 2 diabetes (>2 years since 
diagnosis, 59±6 years of age) and ten sedentary, age-matched men (58±7 years) without diabetes 
were recruited. Insulin resistance in the group with diabetes was 5.2±3.8 10/%S, calculated via 
the Homeostasis Model Assessment for Insulin Resistance (HOMA-IR) (Matthews et al. 1985) 
as HOMA-IR=(glucose(mmol/L)*insulin(mmol/L))/22.5. Exclusion criteria included overt 
cardiovascular disease (previously diagnosed by a physician), smoking in the last 15 years, type I 
diabetes mellitus, age <40 or >65, and diabetes-related manifest vascular complications, 
neuropathy. The study procedures were approved by the medical ethical committee of the 
Radboud University Nijmegen Medical Centre and adhered to the Declaration of Helsinki. All 
subjects gave written informed consent before participation in this study. 
 
Experimental Measures 
Subjects were allocated to 8-weeks lower limb-dominant exercise training (3 exercise sessions 
per week). Each exercise session was supervised by a well-trained researcher and consisted of a 
5-minute warming-up, followed by a circuit of resistance exercises (leg press, calf raise, leg curl, 
leg extension, lower back, abdominal crunch, 3 series of 12 repetitions each, with 1 minute of 
rest between sets within each exercise) interspersed with aerobic activities (e.g. cycling, running) 
(Maiorana et al. 2002; Watts et al. 2004). The total protocol was as follows: 5 minutes warming-
up (cycling), 5 minutes of cycling, leg curl, leg extension, 5 minutes of running, lower back, 
abdominal crunch, 5 minutes of cycling, leg press, calf raise, 5 minutes of running. The total 
duration of a training session was approximately 60 minutes. A heart rate monitor (Polar Electro 
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Oy, Kempele, Finland) was used to continuously monitor heart rate during the aerobic exercise 
and heart rate was maintained at 70-75% of heart rate reserve. The intensity level for each of the 
resistance exercises was set at a level which enables the participant to complete the three series 
of 12 repetitions. Intensity was increased each week under the guidance of the trainers. If a 
participant missed a supervised exercise session, an extra session was planned in the same or 
following week, so that each participant performed a total of 24 supervised sessions (100% 
compliance). Assessments were performed before and after 8-week combined resistance and 
aerobic exercise training. A subset of our type 2 diabetes participants (n=8) also received a dual 
endothelin-receptor blocker (Bosentan, Actelion Pharmaceuticals) during the first 4 weeks 
represented 62.5 mg taken orally twice per day, followed by four weeks of 125 mg twice daily 
(Monfredi et al. 2011). A priori we expected no impact of this intervention on arterial wall 
thickness and, to increase the power of our study, we have combined these subjects with type 2 
diabetes patients that performed exercise training only (n=12). However, to acknowledge any 
possible impact of Bosentan on our outcome parameters, we perform an extra statistical analysis 
in our type 2 diabetes group with ‘Bosentan’ as an additional factor. All subjects followed the 
same exercise training protocol. 
All studies were conducted in a quiet, temperature controlled environment and each visit for a 
given subject was performed at the same time of day.  Subjects were asked to fast for >4 hours, 
abstain from alcohol and caffeine for 16 hours, and not to perform any exercise for 24 hours 
before testing to exclude variation in resting tone, as this can importantly influence wall 
thickness (Thijssen et al. 2011b). 
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After reporting to the laboratory, anthropometrics were measured, and a venous blood sample 
was taken to determine glucose and insulin (for calculating HOMA-IR), cholesterol, HDL, LDL, 
and triglycerides. Subsequently, subjects were positioned in the supine position on a comfortable 
bed. After a rest period of at least 15 minutes, blood pressure was measured twice using a 
manual sphygmomanometer, and the mean blood pressure was used for analysis. This was 
followed by assessment of baseline diameter and wall thickness at rest of the SFA, BA and CA 
by a trained sonographer. A 10 MHz multifrequency linear array probe attached to a high-
resolution ultrasound machine (T3000, Terason, Burlington, MA) was used to image the artery 
lumen (the area from the intima to lumen border on the near wall to the lumen to intima border 
on the far wall) and far wall thickness (WT). Clearly demarcated intimal-medial boundaries were 
obtained via perpendicular incidence imaging in relation to the orientation of the vessel. Images 
were optimized by using contrast controls on the ultrasound machine, which was consistently 
maintained between arteries for each individual (Potter et al. 2008). Ultrasound parameters were 
set to optimize longitudinal B-mode images of the lumen/arterial wall interface.  Diameter and 
WT was collected from 3 distinct angles and data was recorded for at least 10 seconds at a 
sampling frequency of 30 Hz. Values for lumen and WT were calculated as the average of all 
frames and all angles for each sample. 
 
Assessment of the CA was performed with the subject supine and the neck slightly extended to 
allow scanning of the artery. Images for the CA were made on the proximal 1.5 cm straight 
portion of this artery. This was followed by assessment of the SFA diameter and wall thickness, 
which was performed in the proximal third of the thigh, at least 3 cm distal from the bifurcation. 
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Assessment of the BA was performed on the distal 1/3rd of the upper arm. The repeated 
measurements were made on the same segment of the artery. 
 
On a subsequent day, subjects performed an incremental cycle exercise test to examine maximal 
workload and peak oxygen consumption. Data from this test were used to determine maximal 
heart rate, which was used to calculate work load during exercise training. Each subject 
performed an incremental maximal exercise test on a cycling ergometer (Lode, Excalibur, 
Groningen, the Netherlands) before and after the training program. These tests started at a power 
output of 10 W for 1 min and power output increased by 10 W/min until exhaustion. Subjects 
were instructed to maintain a cadence of between 60 and 80 rpm during the test. We 
continuously recorded oxygen consumption (VO2, in ml O2/kg per min), ventilation (Ve, in 
l/min), respiratory quotient (RQ) (Oxycon IV, Jaeger, Germany) and heart rate (HR, in bpm). 
Furthermore, we measured blood lactate levels (mmol/l) using Accutrend® Lactate (Roche 
Diagnostics GmbH, type 3012522, Mannheim, Germany) before and 2 min after finishing the 
maximal exercise test. For a test to be classified as successful, at least 3 out of the following 4 
criteria had to be met: clinical signs of exhaustion of the participant, respiratory quotient ≥1.10, 
finishing within 10 beats of the maximum predicted heart rate (=220-age), and flattening of VO2 
uptake curve (≤110mL increase during the last minute) (Balady et al. 2010). 
 
Analysis of Conduit Artery Diameter and Wall Thickness. 
Post-test analysis of the CA, BA and SFA was performed by a researcher who was blinded to the 
subject identity and timing of the assessment. Furthermore, we used custom-designed edge-
detection and wall-tracking software which is largely independent of investigator bias (Potter et 
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al. 2007; Potter et al. 2008). Briefly, the echo signal was encoded in real-time and stored as a 
DICOM file using an IMAQ-PCI-1407 card.  Subsequent software analysis of this data was 
performed at 30 Hz using an icon-based graphical programming language and toolkit 
(LabVIEW 6.02, National Instruments, Austin, TX). The initial phase of image analysis 
involved the identification of regions of interest (ROI) on the first frame of every individual 
study. The ROI enables automated calibration for diameters on the B-mode image. A ROI was 
then drawn around the optimal area of the B-mode image and within this ROI a pixel-density 
algorithm automatically identified the angle-corrected near and far-wall e-lines for every pixel 
column within the ROI. The same algorithm also identifies the far wall media-adventitia 
interface. Detection of the near and far wall lumen edges and the far wall media-adventitia 
interface is performed on every frame. We have shown that the diameter measurements using 
this semi-automated software possess an intra-observer CV of 5.1% (Potter et al. 2007).  
Furthermore, our method of WT assessment is closely correlated with a “phantom” artery system 
(Potter et al. 2008). To correct for differences in diameter, we also calculated the wall-to-lumen 
ratio (W:L). 
 
Statistics 
Statistical analyses were performed using SPSS 20.0 (SPSS, Chicago, Illinois). Two-way 
repeated measures ANOVA in both groups were used to examine whether the effect of the 8-
week lower limb-dominant exercise training (‘training’; 0 versus 8 weeks) on arterial diameter, 
wall thickness and wall-to-lumen ratio differed between the arteries (‘artery’; BA, SFA, versus 
CA). Pretraining values were compared between groups using unpaired t-tests. According to 
guidelines we adopted the least significant difference approach to multiple comparisons 
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(Rothman 1990; Perneger 1998). All data are reported as mean (±SD) and statistical significance 
was assumed at P<0.05. 
 
 
RESULTS 
At baseline, participants with type 2 diabetes demonstrated significantly higher weight, BMI, 
glucose, insulin and HOMA-IR, and lower cholesterol, low-density lipoprotein, peak oxygen 
uptake and peak workload compared to their age-matched controls (Table 1). We found no 
significant differences between groups in (systolic and diastolic) blood pressure and 
triglycerides. Across the 8-week exercise training period, there were no significant changes in 
weight, body mass index, systolic blood pressure, HDL, triglycerides, glucose, insulin, and 
HOMA-IR in either type 2 diabetes or controls (Table 1). We found a significant main effect of 
training for peak oxygen uptake, peak workload, diastolic blood pressure, total cholesterol, and 
low-density lipoprotein, whilst these changes after the 8-week exercise training were comparable 
between type 2 diabetes and controls (Table 1). The group with type 2 diabetes significantly used 
more metformin, sulfonyurea, and statin users compared with the control group (Table 1). 
 
Diameter. Prior to exercise training, we found no differences between type 2 diabetes and 
controls in baseline diameter of the BA, SFA and CA. A two-way ANOVA in both groups 
revealed a difference in diameter between vessels in type 2 diabetes and controls (p<0.001, Table 
2), as well as a significant training*vessel interaction in type 2 diabetes (p=0.023, Table 2). 
Subsequent post-hoc testing revealed that training significantly increased BA diameter in type 2 
diabetes, but not in controls (Table 2). 
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Wall thickness. Before exercise training, participants with type 2 diabetes demonstrated a larger 
artery wall thickness than controls in the SFA but not BA and CA. A two-way ANOVA in both 
groups revealed an effect of training on wall thickness in type 2 diabetes, which was 
comparable between arteries (Table 2), but no effect of training on wall thickness in 
controls. Furthermore, we found a difference in wall thickness between vessels in type 2 
diabetes and controls (p<0.001, Table 2).  
 
W:L-ratio. Before training, participants with type 2 diabetes demonstrated a significantly larger 
W:L-ratio than controls in the SFA and BA, but not CA (Table 2). A 2-way ANOVA in type 2 
diabetes revealed that the effect of exercise training on W:L-ratio differed between the 3 vessels 
(Table 2). Post-hoc analysis showed a significant decrease in W:L-ratio in the BA and SFA, but 
not in the CA in type 2 diabetes (Table 2). In controls, the 2-way ANOVA revealed no effect of 
exercise training on conduit artery W:L-ratio (Figure 1). 
 
Bosentan. We performed a separate analysis to examine whether the effect of exercise training 
differed between type 2 diabetes patients with and without Bosentan. Separate 2-way ANOVA 
revealed a significant decline in WT and wall:lumen-ratio in the T2DM patients with Bosentan, 
which was similar across the 3 vessels (Table 3). In contrast, the training effect in the placebo 
group on the wall:lumen-ratio and diameter differed between arteries (Table 3). Whilst no 
changes in CA and SFA were found after training in the subgroup on placebo, a decline in 
brachial artery wall:lumen-ratio was found (Table 3). 
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DISCUSSION 
The aim of this study was to examine whether exercise training in type 2 diabetes leads to site-
specific adaptations on wall thickness in peripheral arteries supplying active (i.e SFA) versus 
inactive (i.e. BA) areas, and central (CA) vessels. Our results suggest that 8 weeks of combined 
aerobic (70-75% of maximal heart rate) and resistance (3 series of 12 repetitions) lower-limb 
based exercise training is associated with a significant decrease in wall thickness and wall-to-
lumen ratio in both the SFA and BA, but not in the CA. These findings suggest that this type of 
exercise training in type 2 diabetes leads to a site-specific adaptation in arterial wall thickness, 
with systemic remodelling of peripheral vessels supplying the active and inactive regions, but no 
adaptation of central arterial wall thickness. 
 
To our knowledge, this study is the first to investigate the effect of exercise training on wall 
thickness in peripheral and central conduit arteries in type 2 diabetes patients. We found that 8 
weeks of exercise training in type 2 diabetes is associated with a significant decrease in arterial 
wall thickness of peripheral arteries (i.e. SFA and BA).  The ability of exercise training to 
decrease peripheral artery wall thickness is in line with some (Thijssen et al. 2013; Thijssen et al. 
2011a; Green et al. 2010), but not all (Thijssen et al. 2007), previous studies which examined 
remodelling of peripheral conduit arteries after exercise training in healthy volunteers. An 
important observation in our study is that we found similar decreases in wall thickness of the BA 
and SFA, whilst subjects performed lower limb-dominant exercise training only. This, together 
with the increase in BA lumen diameter we observed, strongly supports the presence of systemic 
adaptations in wall thickness after exercise training in type 2 diabetes. Interestingly, a recent 
study from Maiorana et al. also reported a significant decrease in BA WT after a similar exercise 
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training protocol in patients with heart failure. This suggests that exercise training, in healthy 
subjects and those with increased cardiovascular risk, has a systemic effect on peripheral conduit 
artery wall thickness (Maiorana et al. 2011). 
 
We found no improvements in the CA after exercise training both in type 2 diabetes and in 
controls, which is in marked contrast to a recent exercise training study from Kadaglou. One 
potential explanation for this discrepancy is the absence of pre-training differences in CA WT 
between patients with type 2 diabetes and controls, as a higher pre-training CA WT would allow 
for a larger decline. For example, Kadaglou et al. (Kadoglou et al. 2013) found a decrease in CA 
WT after training in T2DM patients who demonstrate a much higher CA WT at baseline than in 
our study (± 0.8 mm versus ± 0.6 mm). Another explanation is the duration of the study, which 
was markedly longer in the study by Kadaglou et al. compared to our study. Furthermore, 
Kadaglou et al. only found an effect on CA WT after aerobic exercise training, and not after 
combined exercise training. Therefore, the type of exercise may importantly impact the effect on 
WT. Other previous cross-sectional and longitudinal studies in healthy controls and subjects with 
cardiovascular risk/disease found that exercise training is associated with a decrease in CA WT 
(see review (Thijssen et al. 2012)). Also studies that specifically examined type 2 diabetes 
patients (Kim et al. 2006; Watarai et al. 1999) reported an association between higher physical 
activity levels and smaller CA WT. This suggests that the ability of exercise training to decrease 
WT is not exclusively related to a priori thickening of the arterial wall. Future studies should 
look into specific differences between exercise training durations and modalities in type 2 
diabetes. 
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Alternatively, the site-specific changes observed in our study may relate to a larger adaptive 
response of peripheral vessels for wall thickness compared to the carotid artery. In line with this, 
Moreau and colleagues found that exercise training in post-menopausal women was associated 
with a generally lower wall thickness of the SFA, but not the CA (Moreau et al. 2002). In a 
previous study in older men, we also found no effect of 8-week exercise training on CA WT 
(Thijssen et al. 2007). These site-specific adaptations may relate to the characteristics of the wall, 
contributing to distinct vascular adaptations to stimuli between arteries (Green et al. 2011; 
Thijssen et al.). Future studies should further examine the potential differences in adaptation 
between arteries, and especially the time it takes for central and peripheral arteries to adapt in 
response to exercise training. Taken together, our data endorse the concept that exercise training 
leads to systemic adaptation of conduit artery wall thickness in type 2 diabetes patients, but that 
the effects of exercise training has a site-specific effect on peripheral versus central conduit 
arteries. 
 
The finding of a site-specific adaptation in artery wall thickness renders the question regarding 
the mechanisms involved that relate to adaptation in artery wall thickness. When looking at 
functional as opposed to structural outcome measures, a large number of previous studies in 
animals (Langille et al. 1989; Langille and O'Donnell 1986) and humans (Tinken et al. 2010; 
Rowley et al. 2011) have identified shear stress as the key stimulus for localised adaptation in 
conduit arteries. For example, recent studies in humans found that that adaptation in BA function 
as measured by flow mediated dilation in response to 8-weeks exercise training (Birk et al. 2012; 
Tinken et al. 2010) or heat exposure (Naylor et al. 2011) are abolished in the contra-lateral arm 
when the increases in shear rate are mitigated by subdiastolic cuff inflation. Interestingly, when a 
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similar design was used to examine the importance of the shear rate stimulus for adaptation in 
wall thickness, the abolished shear stimulus did not prevent the decreases in BA WT across 8-
weeks of handgrip training (Thijssen et al. 2011a). This suggests that shear stress may not 
represent the principle stimulus for adaptations in wall thickness. Alternatively, systemic 
hemodynamic stimuli, such as cyclic transmural pressure changes, have been suggested to 
explain the impact of exercise training on WT (Newcomer et al. 2011). Our study provides 
further evidence for the importance of systemic stimuli to induce changes in wall thickness, as 
we found a decrease in BA WT after lower limb-dominant exercise training. Studies, largely 
performed in animals, found that such stimuli are associated with remodelling and anti-
atherogenic effects (e.g. eNOS-expression/activity (Awolesi et al. 1995), EDHF-synthase 
expression (Quilley et al. 1997)). Alternative systemic mechanisms may relate to novel markers, 
such as endothelial progenitor cells (EPCs) and miRNA (Thijssen et al. 2010). Other potential 
systemic, non-hemodynamic factors that may contribute to our findings relate to changes in 
muscle sympathetic nerve activity, vasoconstrictor tone, antioxidant level or inflammation (see 
review (Newcomer et al. 2011)). 
 
Clinical relevance. Previous studies have suggested that arterial wall thickness represents a 
surrogate measure for (the development of) atherosclerosis. More specifically, several studies 
have demonstrated a strong and independent predictive capacity for the CA WT for future 
cardiovascular and cerebrovascular events (Lorenz et al. 2007). Not surprisingly, studies have 
also found predictive capacity of the SFA (Paul et al. 2005) and BA (Sorensen et al. 1997; 
Suessenbacher et al.) WT for future development of cardiovascular events. Our findings, 
therefore, have important clinical relevance. The significant decline in peripheral artery wall 
17 
 
thickness may contribute, at least partly, to the cardioprotective effects of exercise training in 
patients with type 2 diabetes. 
 
Previous studies from our group (Thijssen et al. 2013; Thijssen et al. 2011a) have shown that 8 
weeks of exercise training in young healthy controls resulted in decreases in WT, whilst the 
current study did not reproduce this finding in the control group. A possible explanation for this 
discrepancy could be that a higher physical fitness in the younger subjects in Thijssen’s study led 
to a higher absolute workload during the exercise bouts. The absolute lower workload in our 
study may not have been sufficient to elicit peripheral adaptations in controls. Also, as suggested 
by Maiorana et al. (Maiorana et al. 2011), the type of exercise training may partly explain the 
discrepancies, as the previous studies employed continuous cycling (Thijssen et al. 2013) and 
handgrip (Thijssen et al. 2011a) exercise, as opposed to combined aerobic and strength training 
in the current study.  
 
It is important to emphasise that some of the type 2 diabetes subjects ingested Bosentan. Before 
training we did not expect any impact of Bosentan on wall thickness and/or that Bosentan would 
alter the impact of exercise training on wall thickness in type 2 diabetes. However, a post-hoc 
analysis between type 2 diabetes patients with and without Bosentan revealed a significant 
difference in the impact of exercise training on BA, SFA and CA wall thickness between type 2 
diabetes patients with and without Bosentan. Interestingly, type 2 diabetes patients using 
Bosentan did not demonstrate the site-specific change in diameter and wall:lumen-ratio as 
observed in the pooled data set or in the type 2 diabetes subjects using placebo (Table 3). This 
suggests that Bosentan induces a systemic change in diameter and wall:lumen-ratio, possibly by 
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influencing the vascular tone that, subsequently, can alter diameter and wall:lumen-ratio 
(Thijssen et al. 2011b).  This systemic effect is not present in the placebo group and disappears 
when combining both data sets. Taken together, Bosentan may have contributed somewhat to the 
effects of exercise training on diameter and wall:lumen-ratio. However, since these effects are 
likely to be systemic, the use of Bosentan does not alter the main findings of our study, in that 
exercise training can lead to site-specific adaptations in wall:lumen-ratio.  
 
Limitations. The strengths of our study relate to the highly controlled exercise training, inclusion 
of a control group, within-subject comparisons, the use of semi-automated and validated analysis 
software and the blinded analysis of our data. A potential limitation of our study is the a priori 
differences between type 2 diabetes subjects and controls in physical fitness. The type 2 diabetes 
patients were less fit at baseline, meaning that the window of opportunity for improvement in 
this group was larger than in controls. Another possible limitation is that we did not record WT 
under complete relaxation, effectively eliminating the influence of resting tone on WT (Thijssen 
et al. 2011b). Our results may therefore relate to a lower vascular tone after training. However, 
observation of a similar WT in the carotid artery after exercise training suggests that (systemic) 
changes in vascular tone unlikely explain the main finding of our study. Another limitation is 
that even though subjects were instructed to minimize the gripping of handlebars, we cannot 
fully rule out the possibility that subjects were gripping handlebars during some of the resistance 
exercises. This may have impacted our results, especially the increase in BA diameter may relate 
to a higher activity level of upper limbs as anticipated (Rowley et al. 2011). A final limitation is 
the difference between groups concerning medication use, which is difficult to control for 
statistically or methodologically. Therefore, we cannot rule out the possibility that our 
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results are influenced by the systemic effects of the medication interacting with exercise 
training in patients with type 2 diabetes mellitus. 
 
In conclusion, we found that an 8-week exercise training program in patients with type 2 diabetes 
mellitus is associated with site-specific decreases in WT. As training involved lower limb-
dominant exercise, the significant decrease in WT of both the SFA and BA suggests the presence 
of generalised adaptation in the peripheral arterial wall in arteries that supply active and non-
active regions, respectively. However, the absence of changes in the CA suggests that the effects 
of exercise training on WT differ between peripheral and central vessels. Whether this site-
specific difference relates to the a priori differences in WT between groups or to site-specific 
sensitivity in adaptation remains to be elucidated. Based on the prognostic information of conduit 
artery WT for future cerebro- and cardiovascular events, the site-specific decreases in arterial 
WT may contribute to the beneficial impacts of exercise training on cerebro-and cardio-vascular 
events in type 2 diabetes. 
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Table 1. Anthropometrics and training effects in controls, patients with type 2 diabetes mellitus and controls. Data is presented as 
mean ± SD. P-values represent a two-way repeated measures ANOVA, except for ‘Medication use’, where P-values represent 
Pearson’s χ2.  
 
 Type 2 diabetes Control 2-way ANOVA 
Characteristics Pre Post Pre Post Training Training*Group Group 
Age (yrs) 59±6  58±7    0.738 
Height (cm) 177±6  180±5    0.218 
Weight (kg) 101.5±19.2# 101.0±19.0 87.1±9.1 86.1±9.1 0.253 0.726 0.050 
Body mass index (kg/m2) 32.6±6.3# 32.4±6.2 26.8±3.5 26.9±3.5 0.694 0.694 0.018 
Systolic blood pressure (mmHg) 139±14 135±11 134±17 127±10 0.056 0.522 0.201 
Diastolic blood pressure (mmHg) 85±10 82±7 84±6 80±4 0.031 0.891 0.726 
Blood parameters        
Cholesterol (mmol/L) 4.4±1.1# 4.2±0.9 5.9±1.1 5.6±1.4 0.048 0.733 0.006 
High-density lipoprotein (mmol/L) 1.0±0.4 1.0±0.3 1.3±0.2 1.3±0.2 0.604 0.473 0.032 
Low-density lipoprotein (mmol/L) 2.6±1.0# 2.5±0.9 4.0±1.1 3.6±1.3* 0.031 0.144 0.016 
Triglycerides (mmol/L) 1.9±1.1 1.8±1.8 1.3±0.7 1.6±1.0 0.734 0.485 0.543 
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Glucose (mmol/L) 7.6±2.5# 7.0±1.8 4.9±0.3 4.8±0.6 0.451 0.598 <0.001 
Insulin (mmol/L) 15.1±10.5# 19.3±18.8 6.0±3.1 7.0±4.1 0.271 0.500 0.020 
HOMA-IR (10/%S) 5.2±3.8# 6.7±8.4 1.3±0.7 1.6±1.0 0.381 0.513 0.021 
Maximal cycling test        
Peak Oxygen Uptake (mLO2/min/kg) 22.3±4.8# 24.9±5.1* 33.5±7.8 34.2±9.3 0.032 0.182 0.001 
Peak workload (Watt) 159.0±37.1# 192.9±39.2* 232.8±47.5 265.6.46.7* <0.001 0.888 <0.001 
Medication use        
Insulin 5  0  0.083   
Metformin 14#  0  <0.001   
Sulfonylurea 8#  0  0.020   
DPP4 inhibitor 0  0  -   
Thiazolidinedione 1  0  0.472   
ACE inhibitor 8  1  0.091   
Angiotensin II inhibitor 5  0  0.083   
Diuretic 6  2  0.559   
Statin 15#  2  0.004   
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Beta-blocker 4  0  0.129   
Calcium antagonist 3  0  0.197   
Acetylsalicylic acid 2  0  0.301   
Coumarin derivative 1  0  0.472   
*Post-hoc significantly different from baseline at p<0.05. 
#Post-hoc significantly different from controls at baseline at p<0.05. 
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Table 2. Superficial femoral (SFA), brachial (BA) and carotid (CA) artery diameter, wall thickness and wall:lumen-ratio before 
(‘pre’) and after (‘post’) 8 weeks of exercise training in type 2 diabetes (n=20) and controls (n=10). Data are mean±SD. P-values refer 
to a 2-way repeated measures ANOVA to examine the impact of exercise training (‘Training’) on the SFA, BA and CA (‘Vessel’). 
 
 SFA BA CA 2-way ANOVA 
Diameter (mm) Pre Post Pre Post Pre Post Training Training*Vessel Vessel 
Type 2 diabetes 6.87±0.84 6.93±0.85 4.07±0.57 4.31±0.55* 6.42±0.55 6.38±0.62 0.127 0.023 <0.001 
Controls 6.95±0.65 6.90±0.90 4.43±0.46 4.46±0.43 6.40±0.67 6.19±0.85 0.595 0.728 <0.001 
Wall thickness (mm)         
Type 2 diabetes 0.616±0.059# 0.581±0.073* 0.436±0.044 0.410±0.043* 0.589±0.104 0.587±0.101 0.013 0.322 <0.001 
Controls 0.563±0.045 0.571±0.061 0.419±0.039 0.440±0.050 0.623±0.105 0.595±0.107 0.994 0.214 <0.001 
Wall:lumen-ratio         
Type 2 diabetes 0.090±0.009# 0.085±0.011* 0.109±0.015# 0.096±0.012* 0.092±0.016 0.093±0.016 0.002 0.010 <0.001 
Controls 0.082±0.009 0.084±0.011 0.095±0.008 0.099±0.013 0.098±0.019 0.096±0.014 0.407 0.335 0.020 
*Post-hoc significantly different from baseline at p<0.05. 
#Post-hoc significantly different from controls at baseline at p<0.05.
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Table 3. Superficial femoral (SFA), brachial (BA) and carotid (CA) artery diameter, wall thickness and wall:lumen-ratio before 
(‘pre’) and after (‘post’) 8 weeks of exercise training in type 2 diabetes patients that used Bosentan (n=8) or placebo (n=12). Data are 
mean±SD. P-values refer to a 2-way repeated measures ANOVA to examine the impact of exercise training (‘Training’) on the SFA, 
BA and CA (‘Vessel’). 
 
 SFA BA CA 2-way ANOVA 
Diameter (mm) Pre Post Pre Post Pre Post Training Training*Vessel Vessel 
Bosentan 6.92±1.06 7.10±1.10 3.89±0.61 4.10±0.45 6.26±0.66 6.25±0.78 0.194 0.494 <0.001 
Placebo 6.84±0.71 6.81±0.67 4.18±0.53 4.45±0.58* 6.52±0.47 6.47±0.50 0.411 0.008 <0.001 
Wall thickness (mm)         
Bosentan 0.649±0.071 0.596±0.058 0.417±0.045 0.383±0.029 0.598±0.134 0.556±0.068 0.003 0.897 <0.001 
Placebo 0.595±0.038 0.572±0.083 0.448±0.040 0.428±0.043 0.584±0.085 0.608±0.116 0.485 0.153 <0.001 
Wall:lumen-ratio         
Bosentan 0.095±0.008 0.085±0.010 0.109±0.014 0.094±0.005 0.096±0.022 0.090±0.016 0.003 0.525 0.067 
Placebo 0.088±0.009 0.084±0.012 0.109±0.016 0.098±0.015* 0.090±0.012 0.094±0.016 0.112 0.008 0.003 
*Post-hoc significantly different from baseline at p<0.05. 
